These comprehensive investigations of genetic alterations underlying MPN have revealed that additional somatic mutations co-occur with the driver mutations in JAK2, CALR, and MPL genes in more than half of MPN patients [11,33,44]. This evidence concerns the gene JAK2 and myeloproliferative disorder.